Glembatumumab vedotin (CDX-011) is an antibody-activated small molecule coupling, Glembatumumab vedotin has potent anticancer effects and can be used in the study of triple negative breast cancer (TNBC).
Alternative Names
CDX-011
Signaling Pathways
Cytoskeletal Signaling, Antibody-drug Conjugate/ADC Related